Psychiatric care use among migrants to Sweden compared with Swedish-born residents: a longitudinal cohort study of 5 150 753 people.


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
09 2020
Historique:
received: 09 03 2020
revised: 16 07 2020
accepted: 17 07 2020
entrez: 25 9 2020
pubmed: 26 9 2020
medline: 25 6 2021
Statut: ppublish

Résumé

To investigate differences in psychiatric care use over time between Swedish born and those born abroad who migrate to Sweden. Population-based cohort study analysing linked population and health registers, following individuals born 1944-1990 from 1 January 2005 to 31 December 2016. Time-stratified survival analysis using Cox regression estimated time to psychiatric care use. Population included 5 150 753 individuals with 78.1% Swedish born. Migrant status was coded as Swedish born or migrant. Migrants were grouped by year of immigration and region of origin. The main outcome: psychiatric care use, defined as any psychiatric care; psychiatric inpatient or outpatient care; or use of psychotropics. Migrants arriving before 2005 had a higher use of any psychiatric care relative to Swedish born but migrants arriving 2005 onwards had lower use. Migrants from sub-Saharan Africa and Asia had a lower use of any psychiatric care during the first decade in Sweden whereas migrants from Middle East and North Africa had a higher use, driven by use of psychotropics. The lower use of psychiatric care during the first decade contrasts with higher use among migrants with a longer duration of stay. Psychiatric care use among migrants should be analysed multi-dimensionally, taking duration of stay, region of origin and type of care into account.

Sections du résumé

BACKGROUND
To investigate differences in psychiatric care use over time between Swedish born and those born abroad who migrate to Sweden.
METHODS
Population-based cohort study analysing linked population and health registers, following individuals born 1944-1990 from 1 January 2005 to 31 December 2016. Time-stratified survival analysis using Cox regression estimated time to psychiatric care use. Population included 5 150 753 individuals with 78.1% Swedish born. Migrant status was coded as Swedish born or migrant. Migrants were grouped by year of immigration and region of origin. The main outcome: psychiatric care use, defined as any psychiatric care; psychiatric inpatient or outpatient care; or use of psychotropics.
RESULTS
Migrants arriving before 2005 had a higher use of any psychiatric care relative to Swedish born but migrants arriving 2005 onwards had lower use. Migrants from sub-Saharan Africa and Asia had a lower use of any psychiatric care during the first decade in Sweden whereas migrants from Middle East and North Africa had a higher use, driven by use of psychotropics.
CONCLUSIONS
The lower use of psychiatric care during the first decade contrasts with higher use among migrants with a longer duration of stay. Psychiatric care use among migrants should be analysed multi-dimensionally, taking duration of stay, region of origin and type of care into account.

Identifiants

pubmed: 32972966
pii: bmjgh-2020-002471
doi: 10.1136/bmjgh-2020-002471
pmc: PMC7517566
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 101272/Z/13/Z
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Soc Sci Med. 2009 Jul;69(2):246-57
pubmed: 19539414
Syst Rev. 2017 Apr 11;6(1):78
pubmed: 28399907
Epidemiol Psychiatr Sci. 2017 Oct;26(5):526-534
pubmed: 27353562
Int J Equity Health. 2019 Oct 16;18(1):157
pubmed: 31619247
Int J Ment Health Syst. 2019 Dec 28;13:77
pubmed: 31890002
Glob Health Action. 2013 Jun 27;6:21059
pubmed: 23810108
Lancet Psychiatry. 2019 Apr;6(4):305-317
pubmed: 30846354
Eur J Public Health. 2001 Jun;11(2):147-52
pubmed: 11420800
BMC Health Serv Res. 2014 Aug 13;14:341
pubmed: 25127890
Ethn Health. 2014;19(2):217-39
pubmed: 23844602
Soc Psychiatry Psychiatr Epidemiol. 2017 Jun;52(6):679-687
pubmed: 28378064
Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):726-35
pubmed: 16897791
Soc Psychiatry Psychiatr Epidemiol. 2017 Aug;52(8):949-961
pubmed: 28601943
BMJ. 2016 Mar 15;352:i1030
pubmed: 26979256
BMC Public Health. 2014 Oct 03;14:1030
pubmed: 25278109
Br J Psychiatry. 2019 Oct 14;:1-7
pubmed: 31608849
Global Health. 2016 Aug 25;12(1):47
pubmed: 27558472
PLoS One. 2017 Dec 18;12(12):e0189900
pubmed: 29253855
Methods Mol Biol. 2011;675:215-20
pubmed: 20949391
Crisis. 2020 Jul;41(4):314-317
pubmed: 31859565
Psychiatr Serv. 2015 Aug 1;66(8):798-805
pubmed: 25930043
Br J Psychiatry. 2010 Jan;196(1):75-6
pubmed: 20044667
Adv Psychosom Med. 2013;33:40-55
pubmed: 23816862
Early Interv Psychiatry. 2018 Jun;12(3):355-361
pubmed: 27017924
Ethn Health. 2001 Feb;6(1):5-11
pubmed: 11388086
BMC Med. 2018 Dec 12;16(1):223
pubmed: 30537961
Acta Psychiatr Scand. 2009 Nov;120(5):386-91
pubmed: 19807720
PLoS Med. 2019 Nov 5;16(11):e1002944
pubmed: 31689291
J Epidemiol Community Health. 2013 Oct;67(10):875-81
pubmed: 23868528
Br J Psychiatry. 2006 Apr;188:386-91
pubmed: 16582067
BMJ Open. 2017 Dec 29;7(12):e018899
pubmed: 29289940
Psychol Med. 2020 Jan;50(2):303-313
pubmed: 30722795
Soc Psychiatry Psychiatr Epidemiol. 2013 May;48(5):685-92
pubmed: 22893107
BMC Public Health. 2011 Jun 09;11:450
pubmed: 21658213

Auteurs

Anna-Clara Hollander (AC)

Global Public Health Sciences, Karolinska Institutet, Stockholm, Sweden anna-clara.hollander@ki.se.

Euan Mackay (E)

Global Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.

Hugo Sjöqvist (H)

Global Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.

James B Kirkbride (JB)

Division of Psychiatry, Faculty of Brain Sciences, UCL, London, UK.

Sofie Bäärnhielm (S)

Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Transkulturellt Centrum, Stockholm Region, Stockholm, Sweden.

Christina Dalman (C)

Global Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.
Centrum för epidemiologi och samhällsmedicin, Stockholm Region, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH